Development of Targeted Alpha Therapy from Bench to Bedside
This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.
MORGENSTERN Alfred;
BRUCHERTSEIFER Frank;
2020-03-12
ELSEVIER BV
JRC120174
1939-8654 (online),
https://publications.jrc.ec.europa.eu/repository/handle/JRC120174,
10.1016/j.jmir.2019.06.046 (online),
Additional supporting files
File name | Description | File type | |